Citigroup Issues Positive Forecast for Abbott Laboratories (NYSE:ABT) Stock Price
Abbott Laboratories (NYSE:ABT – Free Report) had its price target lifted by Citigroup from $135.00 to $160.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have a buy rating on the healthcare product maker’s stock. Several other analysts also recently weighed in on the stock. Barclays reissued an “overweight” rating and […]
Abbott Laboratories (NYSE:ABT – Free Report) had its price target lifted by Citigroup from $135.00 to $160.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have a buy rating on the healthcare product maker’s stock. Several other analysts also recently weighed in on the stock. Barclays reissued an “overweight” rating and […]
